Discovery of 14??3??3 Protein–Protein Interaction Inhibitors that Sensitize Multidrug??Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693
…, J Dinić, R Hill, M Rossi, D Colecchia, M Pešić…
Abstract 14-3-3 is a family of highly conserved adapter proteins that is attracting much interest among medicinal chemists. Small-molecule inhibitors of 14-3-3 protein–protein interactions (PPIs) are in high demand, both as tools to increase our understanding of 14-3- 3 actions in human diseases and as leads to develop innovative therapeutic agents. Herein we present the discovery of novel 14-3-3 PPI inhibitors through a multidisciplinary strategy ...